An expensive anti-cholesterol drug called inclisiran could soon be offered to hundreds of thousands of people in England and Wales on the NHS. The drug, which would be administered as a twice-a-year injection, costs around £2,000 per dose, could save about 30,000 lives within a decade.
"Inclisiran represents a potential game-changer in preventing thousands of people from dying prematurely from heart attacks and strokes. We're therefore pleased to be able to recommend it as a cost effective option on the NHS." Said Meindert Boysen, NICE deputy chief executive and director of the Centre for